These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33636938)

  • 21. Resolving Discrepancies in Idylla
    George GV; Liu H; Jajosky AN; Oltvai ZN
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790156
    [No Abstract]   [Full Text] [Related]  

  • 22. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M
    BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.
    Hamadou M; Lopez J; Benzerdjeb N; Cugnet-Anceau C; Schnoering G; Besançon J; Mezrag S; Lapras V; Denier ML; Descotes F; Decaussin-Petrucci M
    Diagn Cytopathol; 2021 Dec; 49(12):1265-1271. PubMed ID: 34698448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing.
    Yeo MK; Jung MK; Lee SY; Lee YM; Hur GM; Kim JM
    J Clin Pathol; 2017 Mar; 70(3):260-265. PubMed ID: 27543599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis.
    De Luca C; Sgariglia R; Nacchio M; Pisapia P; Migliatico I; Clery E; Gragnano G; Campione S; Vigliar E; Malapelle U; De Dominicis G; Bellevicine C; Troncone G
    Diagn Cytopathol; 2020 Apr; 48(4):300-307. PubMed ID: 31904908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Idylla KRAS assay on extracted DNA and de-stained cytology smears: Can we rescue small sample?
    Wei Q; Eltoum IA; Mackinnon AC; Harada S
    Ann Diagn Pathol; 2022 Oct; 60():152023. PubMed ID: 35961282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a fast and fully automated platform to diagnose
    Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
    J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer.
    Saharti S
    Cureus; 2022 Apr; 14(4):e24392. PubMed ID: 35619874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    Solassol J; Vendrell J; Märkl B; Haas C; Bellosillo B; Montagut C; Smith M; O'Sullivan B; D'Haene N; Le Mercier M; Grauslund M; Melchior LC; Burt E; Cotter F; Stieber D; Schmitt FL; Motta V; Lauricella C; Colling R; Soilleux E; Fassan M; Mescoli C; Collin C; Pagès JC; Sillekens P
    PLoS One; 2016; 11(9):e0163444. PubMed ID: 27685259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.
    de Biase D; de Luca C; Gragnano G; Visani M; Bellevicine C; Malapelle U; Tallini G; Troncone G
    J Clin Pathol; 2016 Apr; ():. PubMed ID: 27122185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer.
    Xu Y; Zhang L; Jia L; Ren M; Xue T; Bai Q; Yao Q; Wei R; Zhou X; Zhu X
    J Thorac Dis; 2024 Jan; 16(1):40-50. PubMed ID: 38410581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.
    Gularte-Mérida R; Smith S; Bowman AS; da Cruz Paula A; Chatila W; Bielski CM; Vyas M; Borsu L; Zehir A; Martelotto LG; Shia J; Yaeger R; Fang F; Gardner R; Luo R; Schatz MC; Shen R; Weigelt B; Sánchez-Vega F; Reis-Filho JS; Hechtman JF
    JCO Precis Oncol; 2022 Mar; 6():e2100365. PubMed ID: 35235413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
    Bisschop C; Ter Elst A; Bosman LJ; Platteel I; Jalving M; van den Berg A; Diepstra A; van Hemel B; Diercks GFH; Hospers GAP; Schuuring E
    Melanoma Res; 2018 Apr; 28(2):96-104. PubMed ID: 29232304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
    Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
    BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa.
    Jafari M; Laraqui A; Baba W; Benmokhtar S; Zaitouni SE; Ali AA; Bounaim A; Moujahid M; Tanz R; Mahfoud T; Sbitti Y; Annaz HE; Abi R; Tagajdid MR; Kochri SE; Lahlou IA; Hsaini HE; Belayachi L; Benjouad A; Ichou M; En-Nya A; Ennibi K
    BMC Cancer; 2022 Nov; 22(1):1142. PubMed ID: 36344948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.
    Sherwood JL; Brown H; Rettino A; Schreieck A; Clark G; Claes B; Agrawal B; Chaston R; Kong BSG; Choppa P; Nygren AOH; Deras IL; Kohlmann A
    ESMO Open; 2017; 2(4):e000235. PubMed ID: 29018576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
    Weyn C; Van Raemdonck S; Dendooven R; Maes V; Zwaenepoel K; Lambin S; Pauwels P
    BMC Cancer; 2017 Feb; 17(1):139. PubMed ID: 28201998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.
    Schiefer AI; Parlow L; Gabler L; Mesteri I; Koperek O; von Deimling A; Streubel B; Preusser M; Lehmann A; Kellner U; Pauwels P; Lambin S; Dietel M; Hummel M; Klauschen F; Birner P; Möbs M
    J Mol Diagn; 2016 May; 18(3):370-377. PubMed ID: 26921540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma.
    Barel F; Guibourg B; Lambros L; Le Flahec G; Marcorelles P; Uguen A
    Acta Derm Venereol; 2018 Jan; 98(1):44-49. PubMed ID: 28660280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.